Hypervision Surgical and imec bring real-time AI-enabled spectral imaging to the operating room
By combining real-time AI analytics with video rate on-chip hyperspectral imaging, Hypervision is delivering the first clinically approved platform that gives surgeons live, tissue-level insights for assisted surgery. Imec’s on-chip spectral technology is a cornerstone of this innovation.
Hypervision Surgical, a King’s College London spin-out, is leading a major leap in surgical intelligence through its real-time hyperspectral imaging (HSI) platform, now cleared for clinical use in the USA and UK.
By capturing tissue oxygenation, perfusion, and differentiation at video rate (60 frames per second), Hypervision’s technology enables more precise, informed surgeries – starting with a critical use case in colorectal procedures to reduce anastomotic leakage.
Through a strategic partnership with imec, Hypervision is scaling this breakthrough for widespread clinical adoption. Hypervision’s work is unique in many ways:
- World’s first regulatory-cleared intraoperative hyperspectral imaging system, combining on-chip HSI and real-time AI analytics.
- Real-time tissue insights (e.g., oxygenation, perfusion) at surgical speed – over 60 FPS – integrated directly into existing OR workflows.
- Dual imaging mode in Full HD: conventional color plus real-time quantitative tissue oxygenation maps (StO₂).
Imec’s contributions:
- CMOS-based on-chip spectral sensors: enabling ultra-compact, scalable, repeatable integration for clinical-grade HSI.
- Strategic deep-tech partnership: uniting imec’s spectral hardware innovation with Hypervision’s AI-powered surgical analytics to create the next standard in intraoperative imaging.
Together, Hypervision and imec are translating deep-tech innovation into tangible clinical impact – turning leading edge spectral imaging technology into a practical, scalable tool for everyday surgical decision-making.
Discover more
